CN Stock MarketDetailed Quotes

603998 Hunan Fangsheng Pharmaceutical

Watchlist
  • 10.26
  • -0.16-1.54%
Not Open Jan 2 15:00 CST
4.51BMarket Cap16.50P/E (TTM)

Hunan Fangsheng Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hunan Fangsheng Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
437.71M
--
+21.69%
EPS
--
0.20
--
--
Analyst Rating
Strong Buy

Jan 2, 2025

Hunan Fangsheng Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.131B--
--2024/FY-- / 1.831B--
--2023/FY1.629B / 1.802B--
Mar 31, 20232022/FY1.792B / 1.877B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.131B--
--2024/FY-- / 1.831B--
--2023/FY1.629B / 1.802B--
Mar 31, 20232022/FY1.792B / 1.877B--
--------

Unlock Free Earnings Estimates

Hunan Fangsheng Pharmaceutical Earnings Reports

  • Fangsheng Pharmaceutical: Fangsheng Pharmaceutical Report for the Third Quarter of 2024

    Oct 28, 2024 12:00 ET

  • Fangsheng Pharmaceutical Report for the Third Quarter of 2024

    Oct 28, 2024 12:00 ET

  • Fangsheng Pharmaceutical\'s business data announcement for the first three quarters of 2024

    Oct 28, 2024 12:00 ET

  • Fangsheng Pharmaceutical 2024 Semi-Annual Report

    Aug 28, 2024 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    Geovis Insighter Technology
    920116
    35.10 +407.23%
    ESKONJAC
    839273
    25.68 +22.64%
    Xdc Industries(Shenzhen)Limited
    300615
    13.79 +20.02%
    Wuxi Online Offline Communication Information Technology Co., Ltd.
    300959
    52.99 +20.00%
    Shanghai DOBE Cultural & Creative Industry Development
    300947
    19.04 +19.97%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Jan 2, 2025

    Strong Buy

    • Strong Buy

      93.75%

    • Buy

      6.25%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme The Concept of Three Children
    The Concept of Three Children
    Intraday-0.76%
    Cosmetics Concept
    Cosmetics Concept
    Intraday-1.18%
    Innovative Drugs
    Innovative Drugs
    Intraday-1.98%